Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Association between local inflammation and breast tissue age-related lobular involution among premenopausal and postmenopausal breast cancer patients.

Hanna M, Dumas I, Orain M, Jacob S, Têtu B, Sanschagrin F, Bureau A, Poirier B, Diorio C.

PLoS One. 2017 Aug 28;12(8):e0183579. doi: 10.1371/journal.pone.0183579. eCollection 2017.

2.

Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast Cancer.

Furrer D, Jacob S, Caron C, Sanschagrin F, Provencher L, Diorio C.

Anticancer Res. 2017 Jun;37(6):3323-3329.

PMID:
28551685
3.

Association between expression of inflammatory markers in normal breast tissue and mammographic density among premenopausal and postmenopausal women.

Hanna M, Dumas I, Orain M, Jacob S, Têtu B, Sanschagrin F, Bureau A, Poirier B, Diorio C.

Menopause. 2017 May;24(5):524-535. doi: 10.1097/GME.0000000000000794.

PMID:
28002200
4.

Tissue Microarray Is a Reliable Tool for the Evaluation of HER2 Amplification in Breast Cancer.

Furrer D, Jacob S, Caron C, Sanschagrin F, Provencher L, Diorio C.

Anticancer Res. 2016 Sep;36(9):4661-6.

PMID:
27630309
5.

Advantages and disadvantages of technologies for HER2 testing in breast cancer specimens.

Furrer D, Sanschagrin F, Jacob S, Diorio C.

Am J Clin Pathol. 2015 Nov;144(5):686-703. doi: 10.1309/AJCPT41TCBUEVDQC. Review.

PMID:
26486732
6.

ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomas.

Duval C, de Tayrac M, Sanschagrin F, Michaud K, Gould PV, Saikali S.

PLoS One. 2014 Jun 20;9(6):e100342. doi: 10.1371/journal.pone.0100342. eCollection 2014.

7.

Validation of EP1 antibody clone for estrogen receptor immunohistochemistry in breast cancer.

Diorio C, Laberge S, Caron C, Provencher L, Hogue JC, Sanschagrin F.

Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):613-8. doi: 10.1097/PAI.0000000000000001.

PMID:
24897073
8.

Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.

Mouriaux F, Sanschagrin F, Diorio C, Landreville S, Comoz F, Petit E, Bernaudin M, Rousseau AP, Bergeron D, Morcos M.

Invest Ophthalmol Vis Sci. 2014 Mar 4;55(3):1277-83. doi: 10.1167/iovs.13-13345.

PMID:
24481264
9.

Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.

Furrer D, Jacob S, Caron C, Sanschagrin F, Provencher L, Diorio C.

Diagn Pathol. 2013 Feb 4;8:17. doi: 10.1186/1746-1596-8-17.

10.

Cell culture tracking by multivariate analysis of raw LCMS data.

Michaud FT, Havugimana PC, Duchesne C, Sanschagrin F, Bernier A, Lévesque RC, Garnier A.

Appl Biochem Biotechnol. 2012 Jun;167(3):474-88. doi: 10.1007/s12010-012-9661-4. Epub 2012 May 5.

PMID:
22562494
11.

Immunohistochemistry of breast tumor markers on archived bouin-fixed paraffin-embedded tissues.

Gagnon JF, Sanschagrin F, Jacob S, Provencher L, Morin C, Diorio C.

Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):168-72. doi: 10.1097/PAI.0b013e3181f104a1.

PMID:
20930615
12.

Quantitative DNA methylation analysis of laser capture microdissected formalin-fixed and paraffin-embedded tissues.

Gagnon JF, Sanschagrin F, Jacob S, Tremblay AA, Provencher L, Robert J, Morin C, Diorio C.

Exp Mol Pathol. 2010 Feb;88(1):184-9. doi: 10.1016/j.yexmp.2009.09.020. Epub 2009 Oct 8.

PMID:
19818762
13.

Pseudomonas aeruginosa MurE amide ligase: enzyme kinetics and peptide inhibitor.

Paradis-Bleau C, Lloyd A, Sanschagrin F, Maaroufi H, Clarke T, Blewett A, Dowson C, Roper DI, Bugg TD, Levesque RC.

Biochem J. 2009 Jun 26;421(2):263-72. doi: 10.1042/BJ20081395.

PMID:
19400768
14.

The sensor kinase PhoQ mediates virulence in Pseudomonas aeruginosa.

Gooderham WJ, Gellatly SL, Sanschagrin F, McPhee JB, Bains M, Cosseau C, Levesque RC, Hancock REW.

Microbiology. 2009 Mar;155(Pt 3):699-711. doi: 10.1099/mic.0.024554-0.

PMID:
19246741
15.

Phage display-derived inhibitor of the essential cell wall biosynthesis enzyme MurF.

Paradis-Bleau C, Lloyd A, Sanschagrin F, Clarke T, Blewett A, Bugg TD, Levesque RC.

BMC Biochem. 2008 Dec 19;9:33. doi: 10.1186/1471-2091-9-33.

16.

Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa.

Winstanley C, Langille MG, Fothergill JL, Kukavica-Ibrulj I, Paradis-Bleau C, Sanschagrin F, Thomson NR, Winsor GL, Quail MA, Lennard N, Bignell A, Clarke L, Seeger K, Saunders D, Harris D, Parkhill J, Hancock RE, Brinkman FS, Levesque RC.

Genome Res. 2009 Jan;19(1):12-23. doi: 10.1101/gr.086082.108. Epub 2008 Dec 1.

17.

Functional genomics of PycR, a LysR family transcriptional regulator essential for maintenance of Pseudomonas aeruginosa in the rat lung.

Kukavica-Ibrulj I, Sanschagrin F, Peterson A, Whiteley M, Boyle B, MacKay J, Levesque RC.

Microbiology. 2008 Jul;154(Pt 7):2106-2118. doi: 10.1099/mic.0.2007/011239-0.

PMID:
18599838
18.

Essential genes in the infection model of Pseudomonas aeruginosa PCR-based signature-tagged mutagenesis.

Sanschagrin F, Kukavica-Ibrulj I, Levesque RC.

Methods Mol Biol. 2008;416:61-82. doi: 10.1007/978-1-59745-321-9_5.

PMID:
18392961
19.

In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection.

Kukavica-Ibrulj I, Bragonzi A, Paroni M, Winstanley C, Sanschagrin F, O'Toole GA, Levesque RC.

J Bacteriol. 2008 Apr;190(8):2804-13. Epub 2007 Dec 14.

20.

Sigma factors in Pseudomonas aeruginosa.

Potvin E, Sanschagrin F, Levesque RC.

FEMS Microbiol Rev. 2008 Jan;32(1):38-55. Epub 2007 Dec 7. Review.

21.

Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phiKZ gp144 lytic transglycosylase.

Paradis-Bleau C, Cloutier I, Lemieux L, Sanschagrin F, Laroche J, Auger M, Garnier A, Levesque RC.

FEMS Microbiol Lett. 2007 Jan;266(2):201-9.

22.

Parallel solid synthesis of inhibitors of the essential cell division FtsZ enzyme as a new potential class of antibacterials.

Paradis-Bleau C, Beaumont M, Sanschagrin F, Voyer N, Levesque RC.

Bioorg Med Chem. 2007 Feb 1;15(3):1330-40. Epub 2006 Nov 10.

PMID:
17157508
23.

A peptide inhibitor of MurA UDP-N-acetylglucosamine enolpyruvyl transferase: the first committed step in peptidoglycan biosynthesis.

Molina-López J, Sanschagrin F, Levesque RC.

Peptides. 2006 Dec;27(12):3115-21. Epub 2006 Oct 9.

PMID:
17030076
24.

Selection of peptide inhibitors against the Pseudomonas aeruginosa MurD cell wall enzyme.

Paradis-Bleau C, Beaumont M, Boudreault L, Lloyd A, Sanschagrin F, Bugg TD, Levesque RC.

Peptides. 2006 Jul;27(7):1693-700. Epub 2006 Mar 6.

PMID:
16517013
25.

Comparative signature-tagged mutagenesis identifies Pseudomonas factors conferring resistance to the pulmonary collectin SP-A.

Zhang S, Chen Y, Potvin E, Sanschagrin F, Levesque RC, McCormack FX, Lau GW.

PLoS Pathog. 2005 Nov;1(3):259-68. Epub 2005 Nov 25.

26.

Peptide inhibitors of the essential cell division protein FtsA.

Paradis-Bleau C, Sanschagrin F, Levesque RC.

Protein Eng Des Sel. 2005 Feb;18(2):85-91. Epub 2005 Mar 24.

PMID:
15790573
27.

A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display.

Sanschagrin F, Levesque RC.

J Antimicrob Chemother. 2005 Feb;55(2):252-5. Epub 2005 Jan 19.

PMID:
15659541
28.

Heterogeneity among virulence and antimicrobial resistance gene profiles of extraintestinal Escherichia coli isolates of animal and human origin.

Maynard C, Bekal S, Sanschagrin F, Levesque RC, Brousseau R, Masson L, Larivière S, Harel J.

J Clin Microbiol. 2004 Dec;42(12):5444-52.

29.

Identification of Pseudomonas aeruginosa FtsZ peptide inhibitors as a tool for development of novel antimicrobials.

Paradis-Bleau C, Sanschagrin F, Levesque RC.

J Antimicrob Chemother. 2004 Jul;54(1):278-80. Epub 2004 Jun 9. No abstract available.

PMID:
15190020
30.

Identification of novel pathogenicity genes by PCR signature-tagged mutagenesis and related technologies.

Lehoux DE, Sanschagrin F, Kukavica-Ibrulj I, Potvin E, Levesque RC.

Methods Mol Biol. 2004;266:289-304.

PMID:
15148424
31.

In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets.

Potvin E, Lehoux DE, Kukavica-Ibrulj I, Richard KL, Sanschagrin F, Lau GW, Levesque RC.

Environ Microbiol. 2003 Dec;5(12):1294-308.

PMID:
14641575
32.

Antimicrobial resistance genes in enterotoxigenic Escherichia coli O149:K91 isolates obtained over a 23-year period from pigs.

Maynard C, Fairbrother JM, Bekal S, Sanschagrin F, Levesque RC, Brousseau R, Masson L, Larivière S, Harel J.

Antimicrob Agents Chemother. 2003 Oct;47(10):3214-21.

33.

Combinatorial enzymatic assay for the screening of a new class of bacterial cell wall inhibitors.

El Zoeiby A, Beaumont M, Dubuc E, Sanschagrin F, Voyer N, Levesque RC.

Bioorg Med Chem. 2003 Apr 3;11(7):1583-92.

PMID:
12628682
34.

Identification of novel inhibitors of Pseudomonas aeruginosa MurC enzyme derived from phage-displayed peptide libraries.

El Zoeiby A, Sanschagrin F, Darveau A, Brisson JR, Levesque RC.

J Antimicrob Chemother. 2003 Mar;51(3):531-43.

PMID:
12615853
35.

Structure and function of the Mur enzymes: development of novel inhibitors.

El Zoeiby A, Sanschagrin F, Levesque RC.

Mol Microbiol. 2003 Jan;47(1):1-12. Review.

36.

Identification of in vivo essential genes from Pseudomonas aeruginosa by PCR-based signature-tagged mutagenesis.

Lehoux DE, Sanschagrin F, Levesque RC.

FEMS Microbiol Lett. 2002 Apr 23;210(1):73-80.

37.

Discovering essential and infection-related genes.

Lehoux DE, Sanschagrin F, Levesque RC.

Curr Opin Microbiol. 2001 Oct;4(5):515-9. Review.

PMID:
11587926
38.

In vitro reconstruction of the biosynthetic pathway of peptidoglycan cytoplasmic precursor in Pseudomonas aeruginosa.

El Zoeiby A, Sanschagrin F, Havugimana PC, Garnier A, Levesque RC.

FEMS Microbiol Lett. 2001 Jul 24;201(2):229-35.

39.

Insights into the molecular basis for the carbenicillinase activity of PSE-4 beta-lactamase from crystallographic and kinetic studies.

Lim D, Sanschagrin F, Passmore L, De Castro L, Levesque RC, Strynadka NC.

Biochemistry. 2001 Jan 16;40(2):395-402.

PMID:
11148033
40.
41.

Structure-function analysis of alpha-helix H4 using PSE-4 as a model enzyme representative of class A beta-lactamases.

Savoie A, Sanschagrin F, Palzkill T, Voyer N, Levesque RC.

Protein Eng. 2000 Apr;13(4):267-74.

PMID:
10810158
42.

Combinatorial biochemistry and shuffling of TEM, SHV and Streptomyces albus omega loops in PSE-4 class A beta-lactamase.

Sanschagrin F, Thériault E, Sabbagh Y, Voyer N, Levesque RC.

J Antimicrob Chemother. 2000 Apr;45(4):517-20.

PMID:
10747830
43.

Evaluation of inhibition of the carbenicillin-hydrolyzing beta-lactamase PSE-4 by the clinically used mechanism-based inhibitors.

Therrien C, Kotra LP, Sanschagrin F, Mobashery S, Levesque RC.

FEBS Lett. 2000 Mar 31;470(3):285-92.

44.

In vivo-induced genes in Pseudomonas aeruginosa.

Handfield M, Lehoux DE, Sanschagrin F, Mahan MJ, Woods DE, Levesque RC.

Infect Immun. 2000 Apr;68(4):2359-62.

45.

Cloning, over-expression and purification of Pseudomonas aeruginosa murC encoding uridine diphosphate N-acetylmuramate: L-alanine ligase.

El Zoeiby A, Sanschagrin F, Lamoureux J, Darveau A, Levesque RC.

FEMS Microbiol Lett. 2000 Feb 15;183(2):281-8.

46.

Thermoregulated Optical Properties of Peptidic Pseudorotaxanes.

Meillon JC, Voyer N, Biron É, Sanschagrin F, Stoddart JF.

Angew Chem Int Ed Engl. 2000 Jan;39(1):143-145.

PMID:
10649355
47.
48.

Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99.

Trépanier S, Knox JR, Clairoux N, Sanschagrin F, Levesque RC, Huletsky A.

Antimicrob Agents Chemother. 1999 Mar;43(3):543-8.

49.

Roles of amino acids 161 to 179 in the PSE-4 omega loop in substrate specificity and in resistance to ceftazidime.

Therrien C, Sanschagrin F, Palzkill T, Levesque RC.

Antimicrob Agents Chemother. 1998 Oct;42(10):2576-83.

50.

Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamases.

Sabbagh Y, Thériault E, Sanschagrin F, Voyer N, Palzkill T, Levesque RC.

Antimicrob Agents Chemother. 1998 Sep;42(9):2319-25.

Supplemental Content

Loading ...
Support Center